Larson Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.18M | Buy |
59,707
+2,967
| +5% | +$343K | 0.23% | 83 |
|
|
2025
Q4 | $5.97M | Sell |
56,740
-1,858
| -3% | -$174K | 0.2% | 89 |
|
|
2025
Q3 | $4.92M | Buy |
58,598
+1,290
| +2% | +$106K | 0.17% | 115 |
|
|
2025
Q2 | $4.54M | Buy |
57,308
+13,562
| +31% | +$1.08M | 0.18% | 111 |
|
|
2025
Q1 | $3.93M | Buy |
43,746
+11,644
| +36% | +$1.09M | 0.19% | 102 |
|
|
2024
Q4 | $3.19M | Buy |
32,102
+3,521
| +12% | +$363K | 0.17% | 112 |
|
|
2024
Q3 | $3.25M | Buy |
28,581
+2,233
| +8% | +$265K | 0.18% | 104 |
|
|
2024
Q2 | $3.26M | Sell |
26,348
-4,376
| -14% | -$564K | 0.22% | 84 |
|
|
2024
Q1 | $4.05M | Buy |
30,724
+6,555
| +27% | +$808K | 0.31% | 62 |
|
|
2023
Q4 | $2.63M | Buy |
24,169
+621
| +3% | +$64.5K | 0.23% | 81 |
|
|
2023
Q3 | $2.42M | Sell |
23,548
-326
| -1% | -$35.1K | 0.24% | 80 |
|
|
2023
Q2 | $2.75M | Buy |
23,874
+102
| +0.4% | +$11.6K | 0.28% | 68 |
|
|
2023
Q1 | $2.53M | Sell |
23,772
-7,516
| -24% | -$811K | 0.27% | 71 |
|
|
2022
Q4 | $3.47M | Buy |
31,288
+16,489
| +111% | +$1.69M | 0.42% | 45 |
|
|
2022
Q3 | $1.27M | Buy |
14,799
+8,659
| +141% | +$773K | 0.18% | 114 |
|
|
2022
Q2 | $560K | Buy |
6,140
+200
| +3% | +$17.7K | 0.1% | 95 |
|
|
2022
Q1 | $487K | Buy |
5,940
+1,332
| +29% | +$105K | 0.08% | 111 |
|
|
2021
Q4 | $353K | Buy |
4,608
+1,907
| +71% | +$152K | 0.06% | 145 |
|
|
2021
Q3 | $203K | Sell |
2,701
-217
| -7% | -$16.5K | 0.04% | 150 |
|
|
2021
Q2 | $227K | Buy |
2,918
+285
| +11% | +$21.2K | 0.05% | 119 |
|
|
2021
Q1 | $194K | Buy |
2,633
+7
| +0.3% | +$516 | 0.06% | 117 |
|
|
2020
Q4 | $205K | Buy |
2,626
+5
| +0.2% | +$382 | 0.07% | 96 |
|
|
2020
Q3 | $207K | Sell |
2,621
-100
| -4% | -$7.83K | 0.09% | 88 |
|
|
2020
Q2 | $201K | Buy |
2,721
+6
| +0.2% | +$452 | 0.1% | 94 |
|
|
2020
Q1 | $199K | Sell |
2,715
-129
| -5% | -$10.1K | 0.12% | 77 |
|
|
2019
Q4 | $247K | Sell |
2,844
-161
| -5% | -$13.2K | 0.14% | 69 |
|
|
2019
Q3 | $241K | Buy |
3,005
+264
| +10% | +$21.2K | 0.16% | 66 |
|
|
2019
Q2 | $219K | Buy |
2,741
+11
| +0.4% | +$842 | 0.16% | 57 |
|
|
2019
Q1 | $217K | Buy |
2,730
+13
| +0.5% | +$972 | 0.17% | 53 |
|
|
2018
Q4 | $198K | Buy |
+2,717
| New | +$192K | 0.18% | 53 |
|
Other funds holding MRK
VCM
VPM
Larson Financial Group's MRK Position: Q1 2026 in Review
Larson Financial Group increased its Merck (MRK) stake by 5.2% in Q1 2026, buying an estimated $343K and bringing the position to 59,707 shares worth $7.18M. The position accounts for 0.23% of the portfolio, ranked #83.
Larson Financial Group first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Larson Financial Group held 59,707 shares of Merck worth $7.18M as of Q1 2026.
- Larson Financial Group bought 2,967 Merck shares in Q1 2026, an estimated $343K.
- Merck made up 0.23% of Larson Financial Group's portfolio in Q1 2026, its #83 holding.
- Larson Financial Group first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.